Quantifying the benefits and harms of screening mammography

JAMA Internal Medicine

Volumn 174, Issue 3, 2014, Pages 448-453

  Gilbert Welch, H ^a   Passow, Honor J ^a  

^a DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; FALSE POSITIVE RESULT; HUMAN; MAMMOGRAPHY; MEDICAL DECISION MAKING; PRIORITY JOURNAL; REVIEW;

ADULT; BREAST NEOPLASMS; DECISION MAKING; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; RISK; SENSITIVITY AND SPECIFICITY; UNCERTAINTY;

EID: 84897584925     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.13635     Document Type: Review

References (32)

1. Surveillance, Epidemiology, and End Results Program. SEER*Stat software (seer.cancer.gov/seerstat). Version 8.0.4. April 15, 2013. Bethesda, Maryland: National Cancer Institute. Accessed April 20, 2013.
2. NCI-funded Breast Cancer Surveillance Consortium. Data & Statistics: "Months since previous mammogram." 2012. http://breastscreening. cancer.gov/data/mammography-data.html. Accessed October 1, 2013.
3. Welch HG, Hayes KJ, Frost C. Repeat testing among Medicare beneficiaries. Arch Intern Med. 2012;172(22):1745-1751.
4. Elmore JG, Nakano CY, Koepsell TD, Desnick LM, D'Orsi CJ, Ransohoff DF. International variation in screening mammography interpretations in community-based programs. J Natl Cancer Inst. 2003;95(18):1384-1393. (Pubitemid 37220458)
5. Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med. 2011;155(8):481-492.
6. Braithwaite D, Zhu W, Hubbard RA, et al Breast Cancer Surveillance Consortium. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst. 2013;105(5):334-341.
7. Humphyrey LL, Helfand M, Chan BKS, Woolf SH. Breast Cancer Screening: A Summary of the Evidence. Rockville, MD: Agency for Healthcare Research and Quality. 2002:181-210. AHRQ Publication No. 03-507B.
8. Jørgensen KJ, Keen JD, Gøtzsche PC. Is mammographic screening justifiable considering its substantial overdiagnosis rate and minor effect on mortality? Radiology. 2011;260(3):621-627.
9. Tabár L, Vitak B, Chen TH, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011;260(3):658-663.
10. Black WC, Welch HG. Screening for disease. AJR Am J Roentgenol. 1997;168(1):3-11.
11. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up: a randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med. 2002;137(5, pt 1):305-312. (Pubitemid 34977131)
12. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst. 2000;92(18):1490-1499.
13. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687-1717.
14. Kalager M, Zelen M, Langmark F, Adami H-O. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med. 2010;363(13):1203-1210.
15. Autier P, Boniol M, Gavin A, Vatten LJ. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ. 2011;343:d4411.
16. Centers for Disease Control and Prevention. National Health Interview Survey. http://www.cdc.gov/nchs/nhis/nhis-2008-data-release.htm. Accessed November 18, 2013.
17. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med. 1998;338(16):1089-1096. (Pubitemid 28227478)
18. Christiansen CL, Wang F, Barton MB, et al. Predicting the cumulative risk of false-positive mammograms. J Natl Cancer Inst. 2000;92(20):1657-1666.
19. Baker SG, Erwin D, Kramer BS. Estimating the cumulative risk of false positive cancer screenings. BMC Med Res Methodol. 2003;3(11):11.
20. Smith-Bindman R, Chu PW, Miglioretti DL, et al. Comparison of screening mammography in the United States and the United Kingdom. JAMA. 2003;290(16):2129-2137. (Pubitemid 37432973)
21. Blanchard K, Colbert JA, Kopans DB, et al. Long-term risk of false-positive screening results and subsequent biopsy as a function of mammography use. Radiology. 2006;240(2):335-342.
22. Elmore JG, Wells CK, Lee CH, Howard DH, Feinstein AR. Variability in radiologists' interpretations of mammograms. N Engl J Med. 1994;331(22):1493- 1499. (Pubitemid 24356309)
23. Smith-Bindman R, Chu P, Miglioretti DL, et al. Physician predictors of mammographic accuracy. J Natl Cancer Inst. 2005;97(5):358-367. (Pubitemid 40425954)
24. Elmore JG, Jackson SL, Abraham L, et al. Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy. Radiology. 2009;253(3):641-651.
25. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ. 2006;332(7543):689-692.
26. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102(9):605-613.
27. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367(21):1998-2005.
28. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ. 2009;339:b2587.
29. National Cancer Institute. DevCan-Probability of Developing or Dying of Cancer. http://surveillance.cancer.gov/devcan. Accessed March 11, 2012.
30. Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108(11):2205-2240.
31. Brodersen J, Siersma VD. Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med. 2013;11(2):106-115.
32. US Preventive Services Task Force. Screening for breast cancer: recommendation statement. http://www.uspreventiveservicestaskforce.org/uspstf09/ breastcancer/brcanrs.htm. 2009. Accessed November 18, 2013.